NTRA - Financial Reports List - Natera, Inc. - IntrinsicAlpha

Natera, Inc. NTRA

Healthcare - Medical - Diagnostics & Research - NASDAQ - US

$ 144.35

-3.95 %

$ 19.5 B

Market Cap

-92.96

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	53.02%	31.09%	23.42%
Annual Report	FY	10-K	2024-12-31	56.75%	56.20%	50.19%
Quarterly Report	Q3	8-K	2024-09-30	63.90%	71.02%	64.55%
Quarterly Report	Q2	8-K	2024-06-30	58.13%	66.19%	60.95%
Quarterly Report	Q1	8-K	2024-03-31	52.11%	50.63%	46.27%
Quarterly Report	Q4	8-K	2023-12-31	43.20%	45.27%	40.37%
Annual Report	FY	10-K	2023-12-31	31.99%	20.63%	17.52%
Quarterly Report	Q3	8-K	2023-09-30	27.38%	10.25%	6.78%
Quarterly Report	Q2	8-K	2023-06-30	31.89%	23.66%	21.43%
Quarterly Report	Q1	8-K	2023-03-31	24.53%	1.20%	-0.85%

1